IS:ERIS Eris Lifesciences Limited

Eris Lifesciences Limited develops, manufactures, and commercializes pharmaceutical products in chronic and acute therapeutic areas in India. It has a portfolio of various brands in the cardiovascular, anti-diabetics, neurology, chronic respiratory, chronic pain, vitamins, gastro-intestinal, anti-infectives, gynaecology, hepatoprotectives, hormones, hematology, dermatology, anti-obesity and injury healing therapeutic areas. The company was incorporated in 2007 and is based in Ahmedabad, India.

725.20 INR
As of 01/25/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  India
Country of incorporation:  India
IPO date:  01/08/2018
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   98,694,635,520 INR
Current dividend yield:   1.63%
Sedol:      BYXKYT1

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy